MONOPAR THERAPEUTICS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.66 USD | +1.54% |
|
+5.18% | +94.00% |
| 16/04 | Monopar Therapeutics Files Provisional Patent for New MNPR-101 Construct | MT |
| 16/04 | Monopar Therapeutics Inc. Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings | CI |
Chart calendar Monopar Therapeutics Inc.
ccb771cb7e.Ked76Qx6TlwZEBYDFOrQSrM_OCMuP4HMUj1o_hDfYXw.ZrQ2iEYpfi5dZX9gQKz9CPtbCWRfU9avF1o6rWiHIBgZ1EiYSEwhBStRXw~3dd2eb2302b2135cee91c9e8757dcc39
Upcoming events on Monopar Therapeutics Inc.
Past events on Monopar Therapeutics Inc.
| 28/03/2024 04:30 pm | Q4 2023 Earnings Release |
| 12/10/2023 09:45 pm | Roth Healtcare Opportunities Conference |
| 11/09/2023 04:30 pm | H.C. Wainwright Global Investment Conference |
| 10/08/2023 04:30 pm | Q2 2023 Earnings Release |
| 27/06/2023 08:30 pm | Annual General Meeting |
| 27/06/2023 04:45 am | Lake Radiopharma Forum |
| 20/06/2023 11:00 pm | Maxim Group Virtual Healthcare Conference |
| 11/05/2023 04:30 pm | Q1 2023 Earnings Release |
| 03/04/2023 10:30 pm | Jefferies Radiopharma Innovation Summit |
| 23/03/2023 04:30 pm | Q4 2022 Earnings Release |
| 14/03/2023 01:00 am | Roth Conference |
| 10/12/2022 | American Society of Hematology Meeting |
| 16/11/2022 | Connective Tissue Oncology Society Meeting |
| 10/11/2022 06:30 pm | Q3 2022 Earnings Release |
| 06/10/2022 09:30 pm | Roth Healthcare Opportunities Conference |
| 11/08/2022 05:35 pm | Interim 2022 Earnings Release |
| 28/06/2022 09:30 pm | Annual General Meeting |
| 31/03/2022 02:00 am | Maxim Group Virtual Growth Conference |
| 24/03/2022 05:30 pm | FY 2021 Earnings Release |
| 15/03/2022 02:00 am | Roth Capital Partners Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -4,32 -3,90 -10.97% | -6,51 -6,20 -5% | -9,13 -9,22 1.03% | -10,5 -10,6 0.79% | -8,83 -9,27 4.75% | -10,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 0,00 - | -6,30 -6,24 -1.03% | -9,10 -9,22 1.29% | -10,5 -10,6 0.93% | -8,40 -9,10 7.69% | -9,82 |
|
Net income Million USD | Released Forecast Spread | 0,00 0,00 - | -6,30 -6,21 -1.6% | -9,10 -9,20 1.08% | -10,5 -10,6 0.92% | -8,40 -9,10 7.69% | -9,82 |
|
EPS USD | Released Forecast Spread | 0,00 0,00 - | -0,58 -0,57 -2.65% | -0,73 -0,71 -2.46% | -0,83 -0,83 0% | -0,61 -0,67 8.96% | -0,58 |
| Announcement Date | 27/03/20 | 25/03/21 | 24/03/22 | 23/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -2,68 -2,78 3.42% | -2,46 -3,03 18.97% | -2,76 -2,67 -3.38% | -2,41 -2,93 17.94% | -2,91 -2,73 -6.52% | -2,53 -2,85 11.3% | -2,33 -2,56 9.22% | -2,07 -2,60 20.65% | -1,91 -2,35 18.72% | -2,22 | -2,32 | -2,53 | -2,69 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -15,5 -2,79 -456.07% | -2,46 -2,81 12.72% | -2,76 -2,55 -8.52% | -2,40 -2,99 19.65% | -2,90 -2,71 -6.88% | -2,43 -2,82 13.61% | -2,20 -2,55 13.78% | -1,95 -2,60 24.89% | -1,81 -2,35 22.76% | -2,13 | -2,23 | -2,44 | -2,59 |
|
Net income Million USD | Released Forecast Spread | -15,5 -2,77 -459.73% | -2,46 -3,03 18.98% | -2,76 -2,67 -3.36% | -2,40 -2,93 18.2% | -2,90 -2,73 -6.18% | -2,43 -2,84 14.34% | -2,20 -2,54 13.55% | -1,95 -2,60 24.89% | -1,81 -2,35 22.76% | -2,13 | -2,23 | -2,44 | -2,59 |
|
EPS USD | Released Forecast Spread | -0,21 -0,19 -9.09% | -0,19 -0,24 19.72% | -0,22 -0,21 -4.76% | -0,19 -0,21 9.52% | -0,23 -0,20 -12.75% | -0,19 -0,22 13.64% | -0,16 -0,19 15.79% | -0,14 -0,17 16% | -0,12 -0,17 29.41% | -0,15 | -0,13 | -0,14 | -0,15 |
| Announcement Date | 24/03/22 | 12/05/22 | 11/08/22 | 10/11/22 | 23/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 28/03/24 | - | - | - | - |
More events
Past sector events for Monopar Therapeutics Inc.
| 02/05/2024 05:30 pm | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:00 pm | MODERNA, INC.: Q1 2024 Earnings Release |
| 02/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 02/05/2024 | CELLDEX THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 | MIRUM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 | INTELLIA THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MNPR Stock
- Calendar Monopar Therapeutics Inc.
